FDA Inspection 863938 — Lane, Danielle E MD

Lane, Danielle E MD — FEI 3009286037

The FDA completed an inspection of Lane, Danielle E MD on Jan 31, 2014 in Novato, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 31, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Novato, CA (United States)

Citations

IDCFRDescription
1227021 CFR 1271.65(a)Improper release prevention--storage, I.D.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.